Key result
Preimplantation genetic testing using affected-embryo-based SNP haplotyping with NGS successfully identified euploid, non-carrier embryos, resulting in the birth of a healthy infant without Marfan syndrome.
Why the study?
Preimplantation genetic testing for Marfan syndrome using affected-embryo-based SNP haplotyping with NGS was evaluated for its applicability in monogenetic diseases.
Case Report (n=1)
Affected-embryo-based SNP haplotyping with NGS is a viable approach for preimplantation genetic testing in monogenetic diseases such as Marfan syndrome.
Answers are grounded in this paper and cite their sources.
Supports feasibility of affected-embryo SNP haplotyping for Marfan PGT; leaves open broader validation before clinical adoption.
Marfan syndrome (MFS), an autosomal dominant heritable disease of the connective tissue, is characterized by broad clinical manifestations in the musculoskeletal, cardiovascular, pulmonary, and ocular systems. In this study, a male patient with MFS caused by a heterozygous mutation NM_000138.5(FBN1):c.6037 + 2 T > C in the fibrillin 1 gene (FBN1) underwent preimplantation genetic testing (PGT) by using affected-embryo-based single nucleotide polymorphism (SNP) haplotyping. Multiple displacement amplification was used for whole genome amplification of biopsied trophectoderm cells after controlled ovarian stimulation. Sanger sequencing and next-generation sequencing (NGS) were used to detect the state of FBN1 mutation. A total of 14 blastocysts formed after intracytoplasmic sperm injection were biopsied. After NGS, 60 informative polymorphic SNP markers located upstream and downstream of the FBN1 gene and its pathogenic mutation site were linked to individual alleles. Sanger sequencing further confirmed that 8 blastocysts carried the mutation NM_000138.5(FBN1):c.6037 + 2 T > C, while 6 did not. Four of the non-carriers were euploid verified by copy number variation results. A female infant without MFS was born at 37 weeks gestation after a subsequent frozen embryo transfer. In conclusion, the successful case indicates that SNP haplotyping using sibling embryos as a reference is applicable to PGT in monogenetic diseases.Abbreviations MFS: Marfan syndrome; PGT: preimplantation genetic testing; FBN1: fibrillin 1 gene; NGS: next-generation sequencing; SNP: single nucleotide polymorphism.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2021) conducted a case report in Marfan syndrome (n=1). Preimplantation genetic testing (PGT) using affected-embryo-based SNP haplotyping with NGS was evaluated on Identification of non-carrier embryos and birth of a healthy infant. Preimplantation genetic testing using affected-embryo-based SNP haplotyping with NGS successfully identified euploid, non-carrier embryos, resulting in the birth of a healthy infant without Marfan syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: